×
Close
註冊
登入
主页
用户
博客
照片
视频
医学图书S馆
医学图书M馆
医学图书D馆
医学术语
群组
活动
用户工具
用户指南
问答
谁看过我
反馈
语言
English
中文
推广
×
Close
CN1699 Our Business - Guide for Agents
分类
Hematology
6195
Global Medical University
6403
Allergy
1916
Anatomy & Morphology
1737
Andrology
414
Anesthesia & Intensive Care
1446
Anesthesiology
6408
Audiology & Speech-Language Pathology
378
Behavioral Sciences
111
Biochemical Research Methods
8559
Biochemistry & Molecular Biology
35422
Biodiversity Conservation
403
Biology
10453
Biophysics
11497
Biotechnology & Applied Microbiology
10131
Cardiac & Cardiovascular Systems
36427
Cardiovascular & Respiratory Systems
1736
Cell & Tissue Engineering
809
Cell Biology
12677
Chemistry, Analytical
4809
Chemistry, Applied
13339
Chemistry, Medicinal
9947
Chemistry, Multidisciplinary
21706
Clinical Immunology & Infectious Disease
514
Clinical Medicine
10048
Clinical Neurology
19040
Clinical Psychology & Psychiatry
1812
Critical Care Medicine
3792
Dentistry, Oral Surgery & Medicine
15989
Dermatology
8099
Developmental Biology
7761
Ecology
666
Education, Scientific Disciplines
2311
Emergency Medicine
4968
Endocrinology, Metabolism & Nutrition
29144
Engineering, Biomedical
4375
Entomology
510
Environmental Medicine & Public Health
5760
Evolutionary Biology
300
Gastroenterology & Hepatology
14258
General & Internal Medicine
8321
Genetics & Heredity
17997
Geriatrics & Gerontology
5835
Gerontology
378
Health Care Sciences & Services
18997
Health Policy & Services
700
Immunology
30009
Infectious Diseases
16350
Integrative & Complementary Medicine
3423
Medical Ethics
1368
Medical Informatics
2940
Medical Laboratory Technology
433
Medicine, General & Internal
50810
Medicine, Legal
629
Medicine, Research & Experimental
22111
Microbiology
28020
Mycology
0
Nanoscience & Nanotechnology
6393
Neuroimaging
1622
Neurology
5627
Neurosciences
47397
Nursing
10888
Nutrition & Dietetics
8877
Obstetrics & Gynecology
9657
Oncology
62057
Ophthalmology
11852
Optics
5687
Orthopedics
13459
Orthopedics, Rehabilitation & Sports Medicine
2150
Otolaryngology
1748
Otorhinolaryngology
5661
Parasitology
1205
Pathology
5767
Pediatrics
25139
Peripheral Vascular Disease
5521
Pharmacology & Pharmacy
43063
Pharmacology/Toxicology
14498
Physiology
10127
Polymer Science
753
Primary Health Care
953
Psychiatry
24102
Psychology
5922
Psychology, Applied
123
Psychology, Biological
429
Psychology, Clinical
948
Psychology, Developmental
239
Psychology, Educational
166
Psychology, Experimental
163
Psychology, Mathematical
0
Psychology, Multidisciplinary
1721
Psychology, Psychoanalysis
41
Psychology, Social
127
Public Health & Health Care Science
2461
Public, Environmental & Occupational Health
31671
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
14802
Radiology, Nuclear Medicine & Medical Imaging
9277
Rehabilitation
3351
Remote Sensing
0
Reproductive Biology
3527
Reproductive Medicine
1415
Research/Laboratory Medicine & Medical Technology
4757
Respiratory System
8674
Rheumatology
7069
Social Sciences, Biomedical
1349
Substance Abuse
3101
Surgery
40065
Toxicology
4965
Transplantation
960
Tropical Medicine
314
Urology & Nephrology
15502
Veterinary Sciences
35
Virology
2753
Zoology
0
渠道
THERAPEUTIC ADVANCES IN HEMATOLOGY
35
Hematology\Oncology
3
Medrxiv - Hematology
214
AMERICAN JOURNAL OF HEMATOLOGY
248
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
20
BLOOD CANCER JOURNAL
627
BRITISH JOURNAL OF HAEMATOLOGY
460
CIRCULATION RESEARCH
383
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
721
HAEMOPHILIA
143
JOURNAL OF CLINICAL APHERESIS
57
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
258
LANCET HAEMATOLOGY
29
ACTA HAEMATOLOGICA
159
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
166
BLOOD COAGULATION & FIBRINOLYSIS
73
BLOOD PURIFICATION
188
CURRENT OPINION IN HEMATOLOGY
42
EUROPEAN JOURNAL OF HAEMATOLOGY
95
EXPERIMENTAL HEMATOLOGY & ONCOLOGY
312
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
231
HAMOSTASEOLOGIE
220
ASIAN JOURNAL OF TRANSFUSION SCIENCE
20
EGYPTIAN JOURNAL OF HAEMATOLOGY
35
HEMASPHERE
404
HEMATOLOGY REPORTS
17
IRAQI JOURNAL OF HEMATOLOGY
88
CURRENT HEMATOLOGIC MALIGNANCY REPORTS
115
INTERNATIONAL JOURNAL OF HEMATOLOGY
682
JOURNAL OF HEMATOPATHOLOGY
150
SCI时时刷
search
全部
推荐
+
A 10-fold and greater increase in D-dimer at admission in COVID-19 patients is highly predictive of pulmonary embolism in a retrospective cohort study
Background:COVID-19 patients present with both elevated D-dimer and a higher incidence of pulmonary embolism (PE). This si...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Prophylactic management of patients with von Willebrand disease
Von Willebrand disease, the most common inherited bleeding disorder that affects both males and females, is due to quantit...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study
Introduction:Treatment-refractory, acute graft-versus-host disease (GvHD) of the lower gastrointestinal tract (GI) after a...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias
Mitapivat (AG-348) is a novel, first-in-class oral small molecule allosteric activator of the pyruvate kinase enzyme. Mita...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Hepatic venoocclusive disease/sinusoidal obstruction syndrome with normal portal vein flow mimicking aggravated chronic hepatic GVHD following inotuzumab ozogamicin salvage therapy: a case report of pathologic-radiologic discrepancy
Inotuzumab ozogamicin (INO) showed improved treatment outcomes for relapsed or refractory B-cell precursor acute lymphobla...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin
Background:Allogeneic stem cell transplantation (alloSCT) offers cure chance for various hematologic malignancies, but gra...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States
Introduction:The choice of BCR-ABL1 tyrosine kinase inhibitors (TKI) for the first line of therapy (LOT) for chronic-phase...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis
Primary systemic immunoglobulin light chain (AL) amyloidosis is caused by a plasma cell clone of, usually low, malignant p...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Bortezomib in autoimmune hemolytic anemia and beyond
Bortezomib is a first-in-class, potent, selective and reversible proteasome inhibitor approved for the treatment of multip...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma
1. Rodriguez-Abreu, D, Bordoni, A, Zucca, E. Epidemiology of hematological malignancies. Ann Oncol 2007; 18(Suppl. 1): i3–...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations
Introduction:In patients with primary immune thrombocytopenia (ITP), a short course of steroids is routinely given as firs...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Current and emerging treatment options in primary mediastinal B-cell lymphoma
Previously considered a subtype of diffuse large B-cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma (PMBCL) is n...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Case series: MRD negativity assessment using 11C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myeloma
Complete response (CR) is an important favorable factor for survival in multiple myeloma (MM). However, CR patients contin...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Design of an international investigator-initiated study on MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A (MOTIVATE)
Background:Inhibitor development is the most serious treatment-related complication of replacement coagulation factor VIII...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome
Introduction:Donor lymphocyte infusion (DLI) is one of the effective options for post-transplant disease control of myelod...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Emicizumab in acquired haemophilia A: about two clinical cases and literature review
Acquired haemophilia A (AHA) is a rare and severe haemorrhagic autoimmune disease caused by autoantibodies directed agains...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia
The pathological increase of clonal IgM in Waldenström macroglobulinemia can be associated with acquired von Willebrand sy...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia
In recent years, one of the most successful advances in treating acute myeloid leukaemia (AML) has been the combination of...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Challenges of biological monitoring in a hemophilia A patient without inhibitors on emicizumab undergoing major orthopedic surgery: a case report
A man with severe hemophilia A (HA) without factor VIII (FVIII) inhibitors was admitted for total arthroplasty of his elbo...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Addition of chemotherapy to nivolumab after PD-1 inhibitor failure as bridge to allogeneic stem cell transplantation in classical Hodgkin’s lymphoma: report on three cases and literature review
The poor prognosis of refractory or relapsed (R/R) classical Hodgkin’s lymphoma (cHL) after autologous stem cell transplan...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study
Background:Daratumumab (Dara) is generally well tolerated, but is associated with increased risk of infection.Methods:We i...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Clinical features of DDX41 mutation-related diseases: a systematic review with individual patient data
Background:DDX41 serves as a DNA sensor in innate immunity and mutated DDX41 is pathogenic, mainly for myeloid neoplasms.M...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
The use of tafasitamab in diffuse large B-cell lymphoma
Patients who relapse or are refractory after first-line therapy for diffuse large B-cell lymphoma (DLBCL) frequently have ...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Features of indeterminate results of QuantiFERON-TB Gold In-Tube test in patients with haematological malignancies
Background and aims:The application of QuantiFERON-TB Gold in-Tube (QFT-GIT) in patients with haematological malignancies ...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma
Aims:This study quantifies the value of survival gains attributable to novel treatments approved since 2003 for United Sta...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
CORRIGENDUM to “Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?”
Access to society journal content varies across our titles. If you have access to a journal via a society or association ...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Treosulfan-based conditioning for inborn errors of immunity
Inborn errors of immunity (IEI) are inherited disorders that lead to defects in the development and/or function of the imm...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications
Diffuse large B-cell lymphoma (DLBCL) represents a group of tumors characterized by substantial heterogeneity in terms of ...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
The role of tazemetostat in relapsed/refractory follicular lymphoma
Large strides have been made in the treatment of follicular lymphoma (FL) over the last few years. Although the majority o...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphoma
Chimeric antigen receptor (CAR) T-cell therapy with axicabtagene ciloleucel (axi-cel) continues to make its way in the tre...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
阅读更多
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin